# Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure

> **NCT02857010** · PHASE1 · TERMINATED · sponsor: **Pere Gines** · enrollment: 23 (actual)

## Conditions studied

- Acute on Chronic Hepatic Failure

## Interventions

- **BIOLOGICAL:** Allogenic mesenchymal stem cells
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02857010
- **Lead sponsor:** Pere Gines
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02
- **Primary completion:** 2018-02
- **Final completion:** 2020-02
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Dificulties to recruit patients and dificulties to obtain MSCs.
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02857010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02857010, "Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02857010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*